(PHILADELPHIA) – The Abramson Cancer Center’s Rena Rowan Breast Center and the Integrated Breast Center at the Joan Karnell Cancer Center recently earned a three-year, full accreditation by the National Accreditation Program for Breast Centers (NAPBC). Conducted by the American College of Surgeons, NAPBC accreditation is granted to centers that have voluntarily committed to provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance. A breast center that achieves NAPBC accreditation has demonstrated a firm commitment to offer its patients every significant advantage in their battle against breast disease.
The NAPBC surveyors praised the two Penn Medicine programs’ “ambitious, multilayered quality initiatives” in clinical care, research, and education for patients and health professionals alike.
“This accreditation is a testament to the wide range of advanced breast cancer care we provide at Penn Medicine,” said Brian Czerniecki, MD, PhD, co-director of the Abramson Cancer Center’s Rena Rowan Breast Center and an associate professor of oncologic surgery. “From preventive care and early diagnosis to cutting-edge treatment and survivorship care, we are proud of the strength and depth of our programs to help breast cancer patients.”
The Rena Rowan Breast Center, located on the Hospital of the University of Pennsylvania campus, and the Integrated Breast Center at Pennsylvania Hospital’s Joan Karnell Cancer Center, achieved compliance with all 27 standards of the NAPBC survey, which includes excellence in radiology, pathology, surgical, medical and radiation oncology, clinical research, reconstruction, nursing care and rehabilitation services. Providing expert patient care during more than 19,000 patient visits per year, the Rena Rowan Breast Center offers diagnosis and treatment for the full spectrum of breast cancers, including rare cases of breast cancer among men, pregnant women, and other complex situations. Dozens of clinical trials underway are paving the way for even more effective treatments.
“Recognition from the NAPBC highlights the high level of care, the integrated, multidisciplinary approach and the range of support programs our centers provide for our breast cancer patients,” said Dahlia Sataloff, MD, director of the Integrated Breast Center and vice-chair of the Department of Surgery at Pennsylvania Hospital.
Other unique aspects of Penn Medicine’s breast centers include one of the nation’s most advanced cancer risk evaluation programs, and research in novel treatments including therapeutic vaccines and drugs to attack the most aggressive, inherited forms of breast cancer. The centers also offer psychosocial and nutrition counseling and access to a robust survivorship care program that addresses post-cancer issues including late effects of chemotherapy drugs and the painful and debilitating arm-swelling condition lymphedema that often follows breast cancer surgery.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 16 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $398 million awarded in the 2012 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2012, Penn Medicine provided $827 million to benefit our community.